AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Truqap (capivasertib) — US YoY by Quarter
Truqap (capivasertib) — US YoY (%) (%)
AstraZeneca Truqap (capivasertib) — US YoY: 18.0% in Q2 2026, down 39.0 pts from a year earlier.
Latest, Q2 2026
18.0%
Period ended Jun 30, 2026
Change on a year earlier
-39.0 pts
57.0% in Q2 2025
History
5 quarters
Since Q2 2025
Sources
5
Documents cited below
Where the Q2 2026 figure comes from
“|| Truqap | 233 | | 37 | | 37 | | 168 | | 18 | | 17 | | n/m | | n/m | | 34 | | n/m | | n/m | | 14 | | 77 | | 85”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Truqap (capivasertib) — US YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 18.0% | -39.0 pts | Form 6-K FY2026Q2 Earnings Release ↗ |
| Q1 2026 | Mar 31, 2026 | 24.0% | – | Form 6-K FY2026Q1 Earnings Release ↗ |
| Q4 2025 | Dec 31, 2025 | 18.0% | – | Form 6-K FY2025Q4 Earnings Release ↗ |
| Q3 2025 | Sep 30, 2025 | 33.0% | – | Form 6-K FY2025Q3 Earnings Release ↗ |
| Q2 2025 | Jun 30, 2025 | 57.0% | – | Form 6-K FY2025Q2 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Truqap (capivasertib) — US YoY (%), quarterly Q2 2025–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-truqap-us-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.